Sprint Bioscience (Sweden) Technical Analysis
| SPRINT Stock | SEK 1.98 0.11 5.26% |
As of the 1st of March, Sprint Bioscience has the Semi Deviation of 1.91, coefficient of variation of 620.07, and Risk Adjusted Performance of 0.1329. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sprint Bioscience, as well as the relationship between them.
Sprint Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sprint, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SprintSprint |
Sprint Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sprint Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sprint Bioscience.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in Sprint Bioscience on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Sprint Bioscience AB or generate 0.0% return on investment in Sprint Bioscience over 90 days. Sprint Bioscience is related to or competes with Spago Nanomedical, Alligator Bioscience, AcouSort, Pila Pharma, and Oncozenge. Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism More
Sprint Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sprint Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sprint Bioscience AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.55 | |||
| Information Ratio | 0.1552 | |||
| Maximum Drawdown | 124.02 | |||
| Value At Risk | (4.19) | |||
| Potential Upside | 8.82 |
Sprint Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sprint Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sprint Bioscience's standard deviation. In reality, there are many statistical measures that can use Sprint Bioscience historical prices to predict the future Sprint Bioscience's volatility.| Risk Adjusted Performance | 0.1329 | |||
| Jensen Alpha | 2.04 | |||
| Total Risk Alpha | 0.8378 | |||
| Sortino Ratio | 0.6512 | |||
| Treynor Ratio | 0.5374 |
Sprint Bioscience March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1329 | |||
| Market Risk Adjusted Performance | 0.5474 | |||
| Mean Deviation | 5.25 | |||
| Semi Deviation | 1.91 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 620.07 | |||
| Standard Deviation | 14.9 | |||
| Variance | 222.12 | |||
| Information Ratio | 0.1552 | |||
| Jensen Alpha | 2.04 | |||
| Total Risk Alpha | 0.8378 | |||
| Sortino Ratio | 0.6512 | |||
| Treynor Ratio | 0.5374 | |||
| Maximum Drawdown | 124.02 | |||
| Value At Risk | (4.19) | |||
| Potential Upside | 8.82 | |||
| Downside Variance | 12.62 | |||
| Semi Variance | 3.64 | |||
| Expected Short fall | (7.09) | |||
| Skewness | 6.91 | |||
| Kurtosis | 51.89 |
Sprint Bioscience Backtested Returns
Sprint Bioscience appears to be very risky, given 3 months investment horizon. Sprint Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0995, which indicates the firm had a 0.0995 % return per unit of risk over the last 3 months. By inspecting Sprint Bioscience's technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please review Sprint Bioscience's Coefficient Of Variation of 620.07, semi deviation of 1.91, and Risk Adjusted Performance of 0.1329 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sprint Bioscience holds a performance score of 7. The entity has a beta of 4.45, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sprint Bioscience will likely underperform. Please check Sprint Bioscience's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Sprint Bioscience's existing price patterns will revert.
Auto-correlation | 0.20 |
Weak predictability
Sprint Bioscience AB has weak predictability. Overlapping area represents the amount of predictability between Sprint Bioscience time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sprint Bioscience price movement. The serial correlation of 0.2 indicates that over 20.0% of current Sprint Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Sprint Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sprint Bioscience Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Sprint Bioscience across different markets.
About Sprint Bioscience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sprint Bioscience AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sprint Bioscience AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sprint Bioscience price pattern first instead of the macroeconomic environment surrounding Sprint Bioscience. By analyzing Sprint Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sprint Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sprint Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.
Sprint Bioscience March 1, 2026 Technical Indicators
Most technical analysis of Sprint help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sprint from various momentum indicators to cycle indicators. When you analyze Sprint charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1329 | |||
| Market Risk Adjusted Performance | 0.5474 | |||
| Mean Deviation | 5.25 | |||
| Semi Deviation | 1.91 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 620.07 | |||
| Standard Deviation | 14.9 | |||
| Variance | 222.12 | |||
| Information Ratio | 0.1552 | |||
| Jensen Alpha | 2.04 | |||
| Total Risk Alpha | 0.8378 | |||
| Sortino Ratio | 0.6512 | |||
| Treynor Ratio | 0.5374 | |||
| Maximum Drawdown | 124.02 | |||
| Value At Risk | (4.19) | |||
| Potential Upside | 8.82 | |||
| Downside Variance | 12.62 | |||
| Semi Variance | 3.64 | |||
| Expected Short fall | (7.09) | |||
| Skewness | 6.91 | |||
| Kurtosis | 51.89 |
Sprint Bioscience March 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sprint stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (1.10) | ||
| Rate Of Daily Change | 0.95 | ||
| Day Median Price | 2.03 | ||
| Day Typical Price | 2.01 | ||
| Price Action Indicator | (0.10) | ||
| Market Facilitation Index | 0.10 |
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |